{"id":1466,"date":"2015-11-27T12:17:00","date_gmt":"2015-11-27T12:17:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/on-grindeks-financial-results-in-the-nine-months-of-2015\/"},"modified":"2022-06-30T12:19:30","modified_gmt":"2022-06-30T12:19:30","slug":"on-grindeks-financial-results-in-the-nine-months-of-2015","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/on-grindeks-financial-results-in-the-nine-months-of-2015\/","title":{"rendered":"Par Grindeks rezult\u0101tiem 2015. gada devi\u0146os m\u0113ne\u0161os"},"content":{"rendered":"\n

\u0160odien, 27. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNASDAQ Riga\u201d iesniegtie 2015. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2015. gada devi\u0146os m\u0113ne\u0161os bija 63,5 milj. eiro, kas ir par 0,3 milj. eiro vai par 0,6% vair\u0101k nek\u0101 2014. gada devi\u0146os m\u0113ne\u0161os. Savuk\u0101rt, koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, 2015. gada devi\u0146os m\u0113ne\u0161os bija 3,9 milj. eiro, kas, sal\u012bdzinot ar 2014. gada devi\u0146iem m\u0113ne\u0161iem, ir palielin\u0101jusies par 0,2 milj. eiro vai 5,7%.<\/p>\n\n\n\n

Bruto pe\u013c\u0146as rentabilit\u0101te 2015. gada devi\u0146os m\u0113ne\u0161os bija 44%, savuk\u0101rt t\u012br\u0101s pe\u013c\u0146as rentabilit\u0101te bija 6,1%. 2015. gada devi\u0146os m\u0113ne\u0161os Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 63 pasaules valst\u012bm kopum\u0101 par 56,9 milj. eiro, kas ir par 2,8 milj. eiro vai par 4,7% maz\u0101k nek\u0101 2014. gada devi\u0146os m\u0113ne\u0161os.<\/p>\n\n\n\n

Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2015. gada devi\u0146os m\u0113ne\u0161os bija 56,5 milj. eiro un ir palielin\u0101jies, sal\u012bdzinot ar iepriek\u0161\u0113j\u0101 gada devi\u0146iem m\u0113ne\u0161iem, par 0,9 milj. eiro vai 1,6%. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2015. gada devi\u0146os m\u0113ne\u0161os sasniedza 32,4 milj. eiro, kas ir par 12,8 milj. eiro vai 28,4% maz\u0101k nek\u0101 2014. gada devi\u0146os m\u0113ne\u0161os. Sal\u012bdzinot ar iepriek\u0161\u0113j\u0101 gada devi\u0146iem m\u0113ne\u0161iem, iev\u0113rojam\u0101kais p\u0101rdo\u0161anas apjoma pieaugums sasniegts \u2013 Arm\u0113nij\u0101 par 20%, Gruzij\u0101 par 39%, Kirgizst\u0101n\u0101 par 16% un Turkmenist\u0101n\u0101 par 22%.<\/p>\n\n\n\n

Pateicoties biznesa diversifik\u0101cijas strat\u0113\u0123ijai un darb\u012bbas att\u012bst\u012bbai jaunos tirgos, p\u0101rdo\u0161anas apjoms Baltijas un cit\u0101s valst\u012bs 2015. gada devi\u0146os m\u0113ne\u0161os sasniedza 24,1 milj. eiro, kas ir par 13,7 milj. eiro vai 2,3 reizes vair\u0101k nek\u0101 2014. gada devi\u0146os m\u0113ne\u0161os. P\u0101rdo\u0161anas apjoms N\u012bderland\u0113, sal\u012bdzinot ar 2014. gada devi\u0146iem m\u0113ne\u0161iem, ir palielin\u0101jies 6,5 reizes, Slov\u0101kij\u0101 \u2013 3 reizes, savuk\u0101rt Vjetnam\u0101 palielin\u0101jies par 91%, Portug\u0101l\u0113 \u2013 par 89% un Polij\u0101 \u2013 par 56%. P\u0101rdo\u0161anas apjoms Latvij\u0101 \u0161\u012b gada devi\u0146os m\u0113ne\u0161os sasniedza 4,7 milj. eiro, kas, sal\u012bdzinot ar iepriek\u0161\u0113j\u0101 gada devi\u0146iem m\u0113ne\u0161iem, ir palielin\u0101jies par 1,7 milj. eiro vai par 57,1%.<\/p>\n\n\n\n

2015. gada devi\u0146os m\u0113ne\u0161os Grindeks ir papildin\u0101jis produktu kl\u0101stu un ieviesis UDHS (ursodeoxycholic acid, ursodeoksiholsk\u0101be) gatavo z\u0101\u013cu formu (kapsulu), k\u0101 ar\u012b uzs\u0101cis \u0161\u012b produkta ra\u017eo\u0161anu un eksportu uz div\u0101m valst\u012bm \u2013 Krieviju un Gruziju. T\u0101d\u0113j\u0101di Grindeks ir papla\u0161in\u0101jis savu pied\u0101v\u0101jumu gastroenter\u0101l\u0101 trakta un vielmai\u0146as z\u0101\u013cu terapeitiskaj\u0101 grup\u0101. Grindeks ir papla\u0161in\u0101jis ar\u012b uztura bag\u0101tin\u0101t\u0101ju kl\u0101stu un ieviesis divus jaunus produktus \u2013 jaun\u0101k\u0101s paaudzes piensk\u0101bo un bifidobakt\u0113riju kompleksu Lactobex\u00ae<\/small> Strong un Herbastress\u00ae<\/small> miegam. Abi produkti tiek izplat\u012bti Baltijas valst\u012bs.<\/p>\n\n\n\n

2015. gada devi\u0146os m\u0113ne\u0161os akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 5,8 milj. eiro, kas ir par 1,6 milj. eiro vai 22% maz\u0101k nek\u0101 2014. gada devi\u0146os m\u0113ne\u0161os. Galvenie Grindeks akt\u012bvo farmaceitisko vielu eksporta tirgi ir ES valstis, ASV, Kan\u0101da un Jap\u0101na. Grindeks piepras\u012bt\u0101k\u0101s akt\u012bv\u0101s farmaceitisk\u0101s vielas 2015. gada devi\u0146os m\u0113ne\u0161os bija oksitoc\u012bns, zopiklons, ftoraf\u016brs, detomid\u012bns un ksilaz\u012bns.<\/p>\n\n\n\n

AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis: \u201eM\u016bsu darb\u012bba jaunajos tirgos sekm\u0113jas iev\u0113rojamos rezult\u0101tos, t\u0101 apliecinot, ka izv\u0113l\u0113t\u0101 biznesa diversifik\u0101cijas strat\u0113\u0123ija ir pareiza. \u012apa\u0161i iepriecino\u0161i \u0161\u012b gada devi\u0146os m\u0113ne\u0161os ir ar\u012b uz\u0146\u0113muma p\u0101rdo\u0161anas r\u0101d\u012bt\u0101ji Latvij\u0101, kas uzr\u0101da vair\u0101k par 57% k\u0101pumu, sal\u012bdzinot ar iepriek\u0161\u0113j\u0101 gada periodu. J\u0101atz\u012bst, ka notikumi un situ\u0101cija mums svar\u012bgajos tirgos \u2013 Krievij\u0101 un Ukrain\u0101 \u2013 joproj\u0101m sp\u0113c\u012bgi ietekm\u0113 akciju sabiedr\u012bbas Grindeks darb\u012bbas rezult\u0101tus, t\u0101p\u0113c, izv\u0113r\u0161ot savu darb\u012bbu jaunos tirgos, m\u0113s, izmantojot pieredzi un zin\u0101\u0161anas, ne maz\u0101k koncentr\u0113simies ar\u012b uz NVS valst\u012bm.\u201d<\/p>\n\n\n\n

Grindeks rezult\u0101ti 2015. gada 9 m\u0113ne\u0161os<\/p>\n\n\n\n

<\/a>Grindeks rezult\u0101ti 2015. gada 9 m\u0113ne\u0161os (479 KB)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u0160odien, 27. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNASDAQ Riga\u201d iesniegtie 2015. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2015. gada devi\u0146os m\u0113ne\u0161os…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1466","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/1466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=1466"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/1466\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=1466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=1466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=1466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}